Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
暂无分享,去创建一个
[1] G. Gross,et al. Reperfusion injury: does it exist? , 2007, Journal of molecular and cellular cardiology.
[2] Renu Virmani,et al. Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.
[3] Yuejin Yang,et al. Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[4] A. Youssef,et al. Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[5] Zhiwei Wu,et al. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. , 2006, Biochemical and biophysical research communications.
[6] E. Braunwald,et al. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfu , 2006, American heart journal.
[7] T. Nakano,et al. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[8] E. Lonn,et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. , 2006, European heart journal.
[9] T. Celik,et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction , 2006, Coronary artery disease.
[10] U. Sechtem,et al. Transient left ventricular dysfunction with apical ballooning (tako–tsubo cardiomyopathy) in Germany , 2006, Clinical Research in Cardiology.
[11] Koichi Inoue,et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. , 2006, European heart journal.
[12] T. L. Pinto,et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. , 2006, Cardiovascular revascularization medicine : including molecular interventions.
[13] J. Cigarroa,et al. Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.
[14] I. Bilic,et al. [Pathophysiology of ischaemia-reperfusion injury]. , 2006, Lijecnicki vjesnik.
[15] S. Solomon,et al. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[16] J. Herrmann. Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.
[17] S. Iliceto,et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. , 2005, Journal of the American College of Cardiology.
[18] G. Finet,et al. Postconditioning the Human Heart , 2005, Circulation.
[19] F. Crea,et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. , 2005, European heart journal.
[20] H. Matsubara,et al. Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using99mTc-tetrofosmin,123I-BMIPP,123I-MIBG and99mTc-PYP myocardial SPECT , 2005, Annals of nuclear medicine.
[21] M. Hori,et al. Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque , 2005, Circulation.
[22] A. Avogaro,et al. Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients , 2005, Circulation.
[23] B. Gersh,et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.
[24] M. Hersberger,et al. Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein , 2005, Circulation.
[25] B. Gersh,et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. , 2005, Journal of the American College of Cardiology.
[26] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[27] Hiroshi Ito,et al. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device. , 2005, Journal of the American College of Cardiology.
[28] T. Yamaki,et al. A case of recurrent chest pain with reversible left ventricular dysfunction and ST segment elevation on electrocardiogram. , 2005, International heart journal.
[29] A. Lerman,et al. Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction , 2004, Annals of Internal Medicine.
[30] H. Matsubara,et al. Ampulla ('takotsubo') cardiomyopathy of both ventricles: evaluation of microcirculation disturbance using 99mTc-tetrofosmin myocardial single photon emission computed tomography and doppler guide wire. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[31] K. Eagle,et al. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times. , 2004, The American journal of cardiology.
[32] H. Matsubara,et al. Ampulla (`Takotsubo') Cardiomyopathy of Both Ventricles , 2004 .
[33] John O. Prior,et al. Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors , 2004, Circulation.
[34] A. Zeiher,et al. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome , 2004, Coronary artery disease.
[35] A. Jaffe,et al. Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. , 2004, The American journal of cardiology.
[36] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[37] R. Bolli,et al. Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy , 2004, Circulation research.
[38] Hiroshi Sato,et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. , 2004, Journal of the American College of Cardiology.
[39] G. Heusch. Coronary microembolization*1 , 2004 .
[40] J. Waller,et al. Mortality in Patients With Microvascular Disease , 2004, Journal of clinical hypertension.
[41] J. Gore,et al. Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study , 2004, Annals of Internal Medicine.
[42] G. Parodi,et al. Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.
[43] Ori Ben-Yehuda,et al. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. , 2004, Journal of the American College of Cardiology.
[44] C. Cannon,et al. The Open Artery Hypothesis: Past, Present, and Future , 1998, Journal of Thrombosis and Thrombolysis.
[45] E. Boerwinkle,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.
[46] Antonio Colombo,et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.
[47] T. Meinertz,et al. Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease , 2003, Circulation.
[48] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[49] K. Nishioka,et al. Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction. , 2003, Internal medicine.
[50] P. Modesti,et al. Immunomediated and Ischemia-Independent Inflammation of Coronary Microvessels in Unstable Angina , 2003, Circulation research.
[51] J. Dubois-Randé,et al. Incomplete Resolution of ST-Segment Elevation Is a Marker of Transient Microcirculatory Dysfunction After Stenting for Acute Myocardial Infarction , 2003, Circulation.
[52] K. Kario,et al. Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[53] H. Sugihara,et al. Assessment ofTakotsubo (ampulla) cardiomyopathy using99mTc-tetrofosmin myocardial SPECT —Comparison with acute coronary syndrome— , 2003, Annals of nuclear medicine.
[54] R. Kloner,et al. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? , 2003, American journal of physiology. Heart and circulatory physiology.
[55] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[56] R. Erbel,et al. Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction , 2002, Circulation.
[57] K. Stokes,et al. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. , 2002, Free radical biology & medicine.
[58] E. Antman,et al. Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. , 2002, American heart journal.
[59] Akiko Maehara,et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. , 2002, Journal of the American College of Cardiology.
[60] G Finet,et al. Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study , 2002, Circulation.
[61] L. Lerman,et al. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. , 2002, Journal of the American College of Cardiology.
[62] M. Graham,et al. Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting , 2002, Circulation.
[63] A. Giusti,et al. Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion , 2002, BMC cardiovascular disorders.
[64] G. Maurer,et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. , 2002, Blood.
[65] P. Serruys,et al. Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome , 2002, Circulation.
[66] J. J. Griffin,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.
[67] H. White,et al. Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes , 2002, Circulation.
[68] H. White,et al. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction. , 2002, American heart journal.
[69] R. Kloner,et al. The “no-reflow” phenomenon: basic science and clinical correlates , 2002, Heart.
[70] Andrew J Taylor,et al. Experimental Rupture of Atherosclerotic Lesions Increases Distal Vascular Resistance: A Limiting Factor to the Success of Infarct Angioplasty , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[71] U. Laufs,et al. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. , 2001, The American journal of cardiology.
[72] P. Ganz,et al. Role of Endothelin-1 in the Active Constriction of Human Atherosclerotic Coronary Arteries , 2001, Circulation.
[73] K. Ranjadayalan,et al. Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. , 2001, Journal of the American College of Cardiology.
[74] H. Sugihara,et al. Assessment of ampulla (Takotsubo) cardiomyopathy with coronary angiography, two-dimensional echocardiography and99mTc-tetrofosmin myocardial single photon emission computed tomography , 2001, Annals of nuclear medicine.
[75] A. Stephanou,et al. Apoptosis of Endothelial Cells Precedes Myocyte Cell Apoptosis in Ischemia/Reperfusion Injury , 2001, Circulation.
[76] H. Ogawa,et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.
[77] L. Becker,et al. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.
[78] A. Schmermund,et al. Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation , 2001, Circulation.
[79] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[80] M. Kern,et al. The coronary no-reflow phenomenon: a review of mechanisms and therapies. , 2001, European heart journal.
[81] A. Lerman,et al. The endothelium: Dysfunction and beyond , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[82] Renu Virmani,et al. Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.
[83] A. Dart,et al. Diurnal Variation in Endothelium-Dependent Vasodilatation Is Not Apparent in Coronary Artery Disease , 2001, Circulation.
[84] H. Ogawa,et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.
[85] R. Erbel,et al. Coronary microembolization. , 2001, Progress in cardiovascular diseases.
[86] R. Califf,et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. , 2001, Journal of the American College of Cardiology.
[87] MasanoriKawasaki,et al. Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans , 2000 .
[88] T Suzuki,et al. Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans: Coronary Angiographic Findings Within 1 Week Before the Onset of Infarction , 2000, Circulation.
[89] K. Okumura,et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[90] I. Tsuji,et al. Increased acute myocardial infarction mortality following the 1995 Great Hanshin-Awaji earthquake in Japan. , 2000, International journal of epidemiology.
[91] R. Testa,et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. , 2000, Circulation.
[92] H. White,et al. ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. , 2000, Circulation.
[93] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.
[94] J. Freyssinet,et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.
[95] A. L'Abbate,et al. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. , 2000, Journal of the American College of Cardiology.
[96] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[97] C. Heeschen,et al. Angiographic findings in patients with refractory unstable angina according to troponin T status. , 1999, Circulation.
[98] M J Davies,et al. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption , 1999, Heart.
[99] R. Califf,et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.
[100] J. Viikari,et al. Early impairment of coronary flow reserve in young men with borderline hypertension. , 1998, Journal of the American College of Cardiology.
[101] L. Matis,et al. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. , 1998, Circulation.
[102] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[103] T. Lehtimäki,et al. Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.
[104] M. Kozáková,et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. , 1997, Hypertension.
[105] W. Edwards,et al. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. , 1997, Circulation.
[106] J. Viikari,et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. , 1996, Journal of the American College of Cardiology.
[107] K. Bailey,et al. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. , 1993, Journal of the American College of Cardiology.
[108] M. Chiariello,et al. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. , 1993, American heart journal.
[109] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[110] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[111] J. Folts. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. , 1991, Circulation.
[112] M. Ishihara,et al. [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. , 1991, Journal of cardiology.
[113] R. Bolli,et al. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning". , 1990, Circulation research.
[114] L. Becker,et al. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. , 1989, Circulation.
[115] C. White,et al. INTENSE MICROVASCULAR CONSTRICTION AFTER ANGIOPLASTY OF ACUTE THROMBOTIC CORONARY ARTERIAL LESIONS , 1989, The Lancet.
[116] R. Virmani,et al. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. , 1987, Circulation.
[117] M. Hori,et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. , 1986, The American journal of physiology.
[118] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[119] Richard J. Jones. Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .
[120] E. Braunwald,et al. Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.
[121] E. Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.
[122] W. Roberts. Coronary Thrombosis and Fatal Myocardial Ischemia , 1974 .
[123] W. Roberts. Editorial: Coronary thrombosis and fatal myocardial ischemia. , 1974, Circulation.